These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 9532910

  • 1. [Diagnostic and prognostic significance of some parameters of nonspecific defense humoral mechanism in patients with lymphedema complicated by erysipelas inflammation].
    Elagina LV, Savchenko TV, Pavlova MV.
    Klin Med (Mosk); 1998; 76(1):25-7. PubMed ID: 9532910
    [Abstract] [Full Text] [Related]

  • 2. [The diagnostic and prognostic significance of the level of circulating immune complexes in patients with recurrent erysipelas].
    Frolov VM, Boĭchenko PK, Peresadin NA.
    Vrach Delo; 1990 Jun; (6):116-8. PubMed ID: 2399704
    [Abstract] [Full Text] [Related]

  • 3. [The pathogenetic and prognostic significance of the level of class-E immunoglobulins in erysipelas].
    Ambalov IuM, Kovalenko AP, Usatkin AV, Khomchenko LN.
    Vrach Delo; 1991 Sep; (9):76-9. PubMed ID: 1759439
    [Abstract] [Full Text] [Related]

  • 4. [The circulating immune complexes in erysipelas: diagnostic and prognostic significance].
    Frolov VM, Rychnev VE, Bala MA.
    Lab Delo; 1986 Sep; (3):159-61. PubMed ID: 2421086
    [No Abstract] [Full Text] [Related]

  • 5. [Significance of circulating immune complexes in patients with erysipelas].
    Frolov VM, Bala MA, Frolov AF, Rychnev VE.
    Vrach Delo; 1985 Jun; (6):102-5. PubMed ID: 3161244
    [No Abstract] [Full Text] [Related]

  • 6. [Erysipelas and lymphedema--egg or hen?].
    Stöberl C, Partsch H.
    Z Hautkr; 1987 Jan 01; 62(1):56-62. PubMed ID: 3577282
    [Abstract] [Full Text] [Related]

  • 7. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM, Peresadin NA, Gaĭdash IS, Baskakov IN, Tishchenko NA.
    Vestn Dermatol Venerol; 1989 Jan 01; (9):47-51. PubMed ID: 2609765
    [Abstract] [Full Text] [Related]

  • 8. [The information value of immunological tests in predicting recurrences of erysipelas].
    Bala MA, Rychnev VE, Tret'iakova NV.
    Vrach Delo; 1990 Jun 01; (6):118-20. PubMed ID: 2399705
    [No Abstract] [Full Text] [Related]

  • 9. Filariasis and erisipela in Santo Domingo.
    Vincent AL, Ureña Rojas CA, Ayoub EM, Ottesen EA, Harden EG.
    J Parasitol; 1998 Jun 01; 84(3):557-61. PubMed ID: 9645857
    [Abstract] [Full Text] [Related]

  • 10. [The erysipelas as complication of a lymph oedema after therapy of mastocarcinomas (author's transl)].
    Keinert K, Schalldach U, Schumann E.
    Strahlentherapie; 1981 Feb 01; 157(2):91-3. PubMed ID: 7222137
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical significance of detecting discrete antigens of group A Streptococcus and their antibodies in the blood of erysipelas patients].
    Cherkasov VL, Anokhina GI, Shikhman AR, Briko NI.
    Klin Med (Mosk); 1995 Feb 01; 73(4):97-8. PubMed ID: 7474846
    [No Abstract] [Full Text] [Related]

  • 14. [The importance of local factors in recurrent erysipelas].
    Stöberl C.
    Z Hautkr; 1985 May 01; 60(9):712, 715-8, 721-3. PubMed ID: 4013460
    [Abstract] [Full Text] [Related]

  • 15. [Indicators of nonspecific resistance of the body in patients with erysipelas].
    Lipkovskaiia IV, Ermolin GA, Sokol AS, Pavlishin VV, Efremov AN.
    Vrach Delo; 1989 Feb 01; (2):107-9. PubMed ID: 2711647
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Microwave effect on immunological response of chronic limb lymphedema].
    Cao W, Zhang D, Gan J.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2000 Mar 01; 14(2):105-9. PubMed ID: 11778187
    [Abstract] [Full Text] [Related]

  • 18. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A.
    Immunol Invest; 2007 Mar 01; 36(4):371-86. PubMed ID: 17691020
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.